Search results for query: *

I don't think this has been already posted. It's an updated review. Below is the abstract (I can't get the full text). Development of Ebselen for the Treatment of Sensorineural Hearing Loss and Tinnitus Highlights Ebselen is the first investigational new drug to advance to Phase 3 in...

Hi @FGG, This could help you: https://www.tinnitustalk.com/posts/503846/

Sorry if this information has already been posted (although I did not find it on the forum). A phase 2a randomised, double-blind, placebo-controlled, parallel-group, add-on clinical trial of ebselen (SPI-1005) as a novel treatment for mania or hypomania Full article...

To administer this emergency treatment for people who have suffered an unforeseeable and irresistible acoustic trauma: exploding tire, airbags...

So to sum up and resume, regarding NIHL (not Meniere), Sound Pharmaceuticals: - did a phase 2 clinical trial with SPI-1005 for Prevention of Temporary Auditory Threshold Shift with healthy subjects https://clinicaltrials.gov/ct2/show/NCT01444846 and the results were good (see attached file), -...

I know we are not talking about the same clinical trial. I am talking about the clinical trial which is mentioned at the end of the article provided by prnewswire: http://www.prnewswire.com/news-rele...ical-trial-in-menieres-disease-300530256.html Quote :" In an earlier Phase 2 clinical trial...

I missed (and nothing was published on this forum) this phase 2 trial entitled: Otoprotection With SPI-1005 for Prevention of Temporary Auditory Threshold Shift https://clinicaltrials.gov/show/NCT01444846 Although, it is listed in the company website pipeline: https://soundpharma.com/pipeline/...